IP Protection for Biologics in the USMCA Incentivizes Future Cures
Dr. Kristina M. L. Acri née Lybecker
Congress is expected to vote on an updated trade agreement with Canada and Mexico in the coming months. The new deal -- the U.S.-Mexico-Canada Agreement -- includes strong intellectual property protections for certain complex prescription drugs.
These provisions should be cause for celebration, especially for patients. The protections will incentivize biopharmaceutical research and encourage the development of future cures.